Integra LifeSciences (NASDAQ:IART – Get Free Report) released its earnings results on Wednesday. The life sciences company reported $0.76 EPS for the quarter, missing the consensus estimate of $0.78 by ($0.02), Briefing.com reports. The business had revenue of $382.40 million for the quarter, compared to analysts’ expectations of $387.22 million. Integra LifeSciences had a net […]
StockNews.com lowered shares of Integra LifeSciences (NASDAQ:IART – Free Report) from a buy rating to a hold rating in a research report report published on Wednesday morning. Several other equities research analysts also recently issued reports on IART. Piper Sandler lowered their price objective on shares of Integra LifeSciences from $55.00 to $44.00 in a […]
Xponance Inc. reduced its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 9.4% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,695 shares of the life sciences company’s stock after selling 904 shares during the period. Xponance Inc.’s holdings in […]
Morgan Stanley lowered shares of Integra LifeSciences (NASDAQ:IART – Free Report) from an equal weight rating to an underweight rating in a research report released on Thursday, MarketBeat Ratings reports. Morgan Stanley currently has $44.00 price target on the life sciences company’s stock. A number of other equities analysts also recently weighed in on the […]
Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) was the target of a significant growth in short interest during the month of July. As of July 31st, there was short interest totalling 2,400,000 shares, a growth of 20.6% from the July 15th total of 1,990,000 shares. Currently, 3.4% of the shares of the company […]